| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018205A1 Secreted polypeptide zalpha30 |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018202A2 Flint analog compounds and formulations thereof |
| 03/15/2001 | WO2001018200A1 Tsg-like gene |
| 03/15/2001 | WO2001018199A1 Chimaeric plant viruses with mucin peptides |
| 03/15/2001 | WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | WO2001018185A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | WO2001018178A1 Nucleic acids and polypeptides of invertebrate bioamine transporter and methods of use |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018175A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | WO2001018173A2 Dominant negative neuropilin-1 |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018061A2 Maize polynucleotides and related polypeptides useful for enhancing disease resistance in crop plants |
| 03/15/2001 | WO2001018060A1 Materials for extracorporeal circulation, adsorbents for diabetic complication factors, containers for eliminating diabetic complication factors and method of eliminating diabetic complication factors |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | WO2001018057A2 Serine protease inhibitors (spn43a) from drosophila |
| 03/15/2001 | WO2001018056A2 Method of gene therapy for improving the efficiency of cancer therapy |
| 03/15/2001 | WO2001018055A1 Flint analog compounds and formulations thereof |
| 03/15/2001 | WO2001018054A1 Monkey gpr14 |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018052A1 Monomeric analogues of human insulin |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018048A2 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018046A2 Ovarian tumor sequences and methods of use therefor |
| 03/15/2001 | WO2001018044A2 Use of semaphorin for modulation of cellular efflux |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018041A2 Flint proteins and formulations thereof |
| 03/15/2001 | WO2001018039A2 INCREASED PRODUCTION OF INTERFERON-$g(a) |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018037A2 A p53-induced protein with a death domain that can promote apoptosis |
| 03/15/2001 | WO2001018036A2 Methods and reagents for regulating gene expression |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018031A2 Peptides and pharmaceutical compositions comprising same |
| 03/15/2001 | WO2001018030A2 Small peptides having potent anti-angiogenic activity |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018020A1 A eukaryotic mechanosensory transduction channel |
| 03/15/2001 | WO2001018019A1 Epithelial protein lost in neoplasm (eplin) |
| 03/15/2001 | WO2001018016A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017559A1 Semaphorin modulation of immune cell migration |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017557A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | WO2001017552A1 Kaposi's sarcoma-associated herpesvirus ks-sm gene product and uses thereof |
| 03/15/2001 | WO2001017550A2 Vaccine against hbv and hpv |
| 03/15/2001 | WO2001017544A1 Peptides that bind to urokinase receptor |
| 03/15/2001 | WO2001017543A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017343A1 Methods for evaluating a compound for its effect on skin |
| 03/15/2001 | WO2001017334A1 Seedless fruit production |
| 03/15/2001 | WO2001002429A3 Angiopoietin-6 and uses thereof |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000073440A8 Pollinosis-associated gene 787 |
| 03/15/2001 | WO2000071152A9 Fibroblast growth factor 10 |
| 03/15/2001 | WO2000071080A3 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 03/15/2001 | WO2000070061A3 Senescence-related promoters |
| 03/15/2001 | WO2000070037A3 Directed evolution of microorganisms |
| 03/15/2001 | WO2000068389A3 Auxin transport proteins |
| 03/15/2001 | WO2000066761A3 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000065061A3 Nucleic acid sequences from candida yeasts which code cytochrome b5 polypeptides |
| 03/15/2001 | WO2000061610A3 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 03/15/2001 | WO2000053730A3 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 03/15/2001 | WO2000049167A8 Latency-associated regulatory region from herpesvirus saimiri (hvs) |
| 03/15/2001 | WO2000014263A8 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them |
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19941768A1 New Schizosaccharomyces pombe mutants with defective potassium uptake useful for expressing human eag related gene in screening assays for potassium ion channel modulators |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE10035472A1 Komplex mit spezifischen dephosphorylierenden Enzymen, deren Effektoren und Verfahren zu ihrer Gewinnung Complex with specific dephosphorylating enzymes whose effectors and process for obtaining |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384499A1 Ovarian tumor sequences and methods of use therefor |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384115A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | CA2384104A1 Use of semaphorin for modulation of cellular efflux |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384014A1 Nucleic and amino acid sequences relating to resistance to blackleg in plants |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2384000A1 Regulatory sequences and expression systems functioning in filamentous fungi |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |